US2013273616A1PendingUtilityA1

Polypeptides and biosynthetic pathways for the production of monatin and its precursors

Assignee: CARGILL INCPriority: Apr 23, 2002Filed: Apr 12, 2013Published: Oct 17, 2013
Est. expiryApr 23, 2022(expired)· nominal 20-yr term from priority
C12P 17/10C12N 15/52
60
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods and compositions that can be used to make monatin from glucose, tryptophan, indole-3-lactic acid, indole-3-pyruvate, and 2-hydroxy 2-(indol-3-ylmethyl)-4-keto glutaric acid, are provided. Methods are also disclosed for producing the indole-3-pyruvate and 2-hydroxy2-(indol-3-ylmethyl)-4-keto glutaric acid intermediates. Compositions provided include nucleic acid molecules, polypeptides, chemical structures, and cells. Methods include in vitro and in vivo processes, and the in vitro methods include chemical reactions.

Claims

exact text as granted — not AI-modified
1 . A method for producing monatin or salt thereof comprising:
 (a) contacting a cell with tryptophan, wherein the cell expresses   (i) a first polypeptide that facilitates the conversion of tryptophan to indole-3-pyruvate;   (ii) a second polypeptide that facilitates the conversion of indole-3-pyruvate to 2-hydroxy2-(indol-3-ylmethyl)-4-keto glutaric acid, wherein the second polypeptide is an aldolase; and   (iii) a third polypeptide that facilitates the conversion of 2-hydroxy2-(indol-3-ylmethyl)-4-keto glutaric acid to monatin or salt thereof;   wherein at least one of the first and third polypeptides are selected from the group consisting of HEXAspC aminotransferase (SEQ ID NO:76) and YfdZ (SEQ ID NO:92);   (b) culturing the cell under conditions whereby monatin or salt thereof is produced; and   (c) harvesting monatin or salt thereof.   
     
     
         2 . The method of  claim 1 , wherein the first polypeptide and the third polypeptide are the same. 
     
     
         3 . The method of  claim 1 , wherein the aldolase is selected from the group consisting of 4-hydroxy-2-oxoglutarate aldolase (KHG) (EC 4.1.3.16) and 4-hydroxy-4-methyl-2-oxoglutarate aldolase (ProA) (EC 4.1.3.17). 
     
     
         4 . The method of  claim 3 , wherein the aldolase is derived from  Z. mobilis, C. testosteroni, S. meliloti, B. japonicum, S. paucimobilis, Y. pestis, R. metallidurans, Y. pseudotuberculosis, R. leguminosarum, N. aromaticivorans, P. putida, M magnetotacticum, R. palustris, X. campestris, X. axonopodis , or  S. avermitilis.    
     
     
         5 . The method of  claim 1 , wherein the cell is an  E. coli  cell. 
     
     
         6 . The method of  claim 1 , wherein one or more of the first, second, and third polypeptides are encoded by an exogenous nucleic acid. 
     
     
         7 . The method of  claim 1 , wherein the tryptophan is D-tryptophan.

Join the waitlist — get patent alerts

Track US2013273616A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.